{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:47Z","timestamp":1792788287957,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82150113"],"award-info":[{"award-number":["82150113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82104453"],"award-info":[{"award-number":["82104453"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chongqing Talent Program-Leading Innovative Talents","award":["CQYC20210303411"],"award-info":[{"award-number":["CQYC20210303411"]}]},{"name":"the Chongqing Key Specialty Construction Project of Clinical Pharmacy","award":["Clinical Pharmacy of Medical oncology"],"award-info":[{"award-number":["Clinical Pharmacy of Medical oncology"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01759-8","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T17:03:34Z","timestamp":1722013414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1"],"prefix":"10.1186","volume":"22","author":[{"given":"Wuyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changpeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsha","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"issue":"6","key":"1759_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrc.2016.37","volume":"16","author":"AH Shain","year":"2016","unstructured":"Shain AH, et al. From melanocytes to melanomas. Nat Rev Cancer. 2016;16(6):345\u201358.","journal-title":"Nat Rev Cancer"},{"key":"1759_CR2","doi-asserted-by":"crossref","unstructured":"Egeler MD et al. Survival is not enough: understanding the mental burden of cutaneous melanoma. Br J Dermatol. 2024.","DOI":"10.1093\/bjd\/ljae050"},{"key":"1759_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","volume":"133","author":"T Hirschhorn","year":"2019","unstructured":"Hirschhorn T, et al. The development of the concept of ferroptosis. Free Radical Bio Med. 2019;133:130\u201343.","journal-title":"Free Radical Bio Med"},{"issue":"7","key":"1759_CR4","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.7150\/thno.54113","volume":"11","author":"XG Wu","year":"2021","unstructured":"Wu XG, et al. Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 2021;11(7):3052\u20139.","journal-title":"Theranostics"},{"key":"1759_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.freeradbiomed.2024.01.003","volume":"212","author":"W Zhou","year":"2024","unstructured":"Zhou W, et al. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. Free Radic Biol Med. 2024;212:493\u2013504.","journal-title":"Free Radic Biol Med"},{"key":"1759_CR6","doi-asserted-by":"publisher","first-page":"155220","DOI":"10.1016\/j.phymed.2023.155220","volume":"123","author":"W Huang","year":"2024","unstructured":"Huang W, et al. Yi-qi-Hua-Yu-Jie-Du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT\/GSK3beta\/NRF2\/GPX4 axis. Phytomedicine. 2024;123:155220.","journal-title":"Phytomedicine"},{"issue":"7","key":"1759_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/np030096l","volume":"66","author":"DJ Newman","year":"2003","unstructured":"Newman DJ, et al. Natural products as sources of new drugs over the period 1981\u20132002. J Nat Prod. 2003;66(7):1022\u201337.","journal-title":"J Nat Prod"},{"issue":"11","key":"1759_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.phymed.2016.06.004","volume":"23","author":"W Jiang","year":"2016","unstructured":"Jiang W, et al. Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines. Phytomedicine. 2016;23(11):1259\u201366.","journal-title":"Phytomedicine"},{"issue":"4","key":"1759_CR9","first-page":"767","volume":"18","author":"T Efferth","year":"2001","unstructured":"Efferth T, et al. The anti-malarial artesunate is also active against cancer. Int J Oncol. 2001;18(4):767\u201373.","journal-title":"Int J Oncol"},{"issue":"2","key":"1759_CR10","first-page":"196","volume":"46","author":"T Efferth","year":"1996","unstructured":"Efferth T, et al. Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung. 1996;46(2):196\u2013200.","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"1759_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0304-3835(94)03716-V","volume":"91","author":"H Lai","year":"1995","unstructured":"Lai H, et al. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett. 1995;91(1):41\u20136.","journal-title":"Cancer Lett"},{"key":"1759_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.phymed.2018.09.178","volume":"54","author":"C von Hagens","year":"2019","unstructured":"von Hagens C, et al. Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33\/2). Phytomedicine. 2019;54:140\u20138.","journal-title":"Phytomedicine"},{"issue":"1","key":"1759_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ygyno.2019.12.035","volume":"157","author":"CL Trimble","year":"2020","unstructured":"Trimble CL, et al. A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3). Gynecol Oncol. 2020;157(1):188\u201394.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1759_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","volume":"81","author":"JF Deeken","year":"2018","unstructured":"Deeken JF, et al. A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies. Cancer Chemother Pharmacol. 2018;81(3):587\u201396.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"1759_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jpha.2023.02.006","volume":"13","author":"J Chen","year":"2023","unstructured":"Chen J, et al. Single-cell transcriptome analysis reveals the regulatory effects of artesunate on splenic immune cells in polymicrobial sepsis. J Pharm Anal. 2023;13(7):817\u201329.","journal-title":"J Pharm Anal"},{"key":"1759_CR16","doi-asserted-by":"publisher","first-page":"113705","DOI":"10.1016\/j.biopha.2022.113705","volume":"155","author":"D Cao","year":"2022","unstructured":"Cao D, et al. Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation. Biomed Pharmacother. 2022;155:113705.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1759_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","volume":"11","author":"M Liu","year":"2018","unstructured":"Liu M, et al. Targeting the IDO1 pathway in cancer: from bench to bedside. J Hematol Oncol. 2018;11(1):100.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"1759_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1158\/2326-6066.CIR-14-0137","volume":"3","author":"I Theate","year":"2015","unstructured":"Theate I, et al. Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues. Cancer Immunol Res. 2015;3(2):161\u201372.","journal-title":"Cancer Immunol Res"},{"issue":"22","key":"1759_CR19","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1158\/1078-0432.CCR-11-1331","volume":"17","author":"J Godin-Ethier","year":"2011","unstructured":"Godin-Ethier J, et al. Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives. Clin Cancer Res. 2011;17(22):6985\u201391.","journal-title":"Clin Cancer Res"},{"issue":"5588","key":"1759_CR20","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1126\/science.1073514","volume":"297","author":"DH Munn","year":"2002","unstructured":"Munn DH, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 2002;297(5588):1867\u201370.","journal-title":"Science"},{"issue":"6","key":"1759_CR21","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 2010;185(6):3190\u20138.","journal-title":"J Immunol"},{"issue":"5","key":"1759_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","volume":"22","author":"DH Munn","year":"2005","unstructured":"Munn DH, et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 2005;22(5):633\u201342.","journal-title":"Immunity"},{"issue":"11","key":"1759_CR23","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","volume":"176","author":"F Fallarino","year":"2006","unstructured":"Fallarino F, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol. 2006;176(11):6752\u201361.","journal-title":"J Immunol"},{"issue":"5","key":"1759_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, et al. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18(5):379\u2013401.","journal-title":"Nat Rev Drug Discov"},{"key":"1759_CR25","doi-asserted-by":"publisher","first-page":"104815","DOI":"10.1016\/j.bioorg.2021.104815","volume":"110","author":"S Chen","year":"2021","unstructured":"Chen S, et al. The ups, downs and new trends of IDO1 inhibitors. Bioorg Chem. 2021;110:104815.","journal-title":"Bioorg Chem"},{"issue":"11","key":"1759_CR26","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1158\/1078-0432.CCR-22-3911","volume":"29","author":"CM Kelly","year":"2023","unstructured":"Kelly CM, et al. A phase II study of Epacadostat and Pembrolizumab in patients with Advanced Sarcoma. Clin Cancer Res. 2023;29(11):2043\u201351.","journal-title":"Clin Cancer Res"},{"issue":"43","key":"1759_CR27","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1759_CR28","doi-asserted-by":"publisher","first-page":"112899","DOI":"10.1016\/j.jim.2020.112899","volume":"487","author":"V Olivo Pimentel","year":"2020","unstructured":"Olivo Pimentel V, et al. A novel co-culture assay to assess anti-tumor CD8(+) T cell cytotoxicity via luminescence and multicolor flow cytometry. J Immunol Methods. 2020;487:112899.","journal-title":"J Immunol Methods"},{"issue":"Suppl 4","key":"1759_CR29","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"issue":"Web Server issu","key":"1759_CR30","doi-asserted-by":"publisher","first-page":"W26","DOI":"10.1093\/nar\/gku477","volume":"42","author":"J Nickel","year":"2014","unstructured":"Nickel J, et al. SuperPred: update on drug classification and target prediction. Nucleic Acids Res. 2014;42(Web Server issue):W26\u201331.","journal-title":"Nucleic Acids Res"},{"key":"1759_CR31","doi-asserted-by":"publisher","first-page":"5080843","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"LJ Su","year":"2019","unstructured":"Su LJ, et al. Reactive Oxygen species-Induced lipid peroxidation in apoptosis, Autophagy, and Ferroptosis. Oxid Med Cell Longev. 2019;2019:5080843.","journal-title":"Oxid Med Cell Longev"},{"key":"1759_CR32","doi-asserted-by":"crossref","unstructured":"Qin R et al. Tryptophan potentiates CD8(+) T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation. J Immunother Cancer. 2021;9(7).","DOI":"10.1136\/jitc-2021-002840"},{"key":"1759_CR33","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jconrel.2023.11.042","volume":"365","author":"X Yang","year":"2024","unstructured":"Yang X, et al. Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1\/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy. J Control Release. 2024;365:654\u201367.","journal-title":"J Control Release"},{"issue":"1","key":"1759_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, et al. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8(1):372.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"1759_CR35","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","volume":"23","author":"T Xu","year":"2019","unstructured":"Xu T, et al. Molecular mechanisms of ferroptosis and its role in cancer therapy. J Cell Mol Med. 2019;23(8):4900\u201312.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1759_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"1759_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"ZJ Li","year":"2021","unstructured":"Li ZJ, et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301\u201310.","journal-title":"Acta Pharmacol Sin"},{"key":"1759_CR38","doi-asserted-by":"crossref","unstructured":"Jochims F et al. The Antimalarial Drug Artesunate mediates selective cytotoxicity by upregulating HO-1 in Melanoma cells. Biomedicines. 2023;11(9).","DOI":"10.3390\/biomedicines11092393"},{"issue":"5","key":"1759_CR39","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.molcel.2022.02.007","volume":"82","author":"A Fiore","year":"2022","unstructured":"Fiore A, et al. Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling. Mol Cell. 2022;82(5):920\u201332. e7.","journal-title":"Mol Cell"},{"issue":"1","key":"1759_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00432-022-04447-7","volume":"149","author":"J Xu","year":"2023","unstructured":"Xu J, et al. The dual role and mutual dependence of heme\/HO-1\/Bach1 axis in the carcinogenic and anti-carcinogenic intersection. J Cancer Res Clin Oncol. 2023;149(1):483\u2013501.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1759_CR41","doi-asserted-by":"crossref","unstructured":"Chiang SK et al. A dual role of Heme Oxygenase-1 in Cancer cells. Int J Mol Sci. 2018;20(1).","DOI":"10.3390\/ijms20010039"},{"key":"1759_CR42","doi-asserted-by":"publisher","first-page":"104642","DOI":"10.1016\/j.yexmp.2021.104642","volume":"120","author":"SMK Gamage","year":"2021","unstructured":"Gamage SMK, et al. Dual role of heme iron in cancer; promotor of carcinogenesis and an inducer of tumour suppression. Exp Mol Pathol. 2021;120:104642.","journal-title":"Exp Mol Pathol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01759-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01759-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01759-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T17:21:58Z","timestamp":1722014518000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01759-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1759"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01759-8","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were performed adhering to the guidelines of the Animal Care and Use Committee of Army Medical University (NO. AMUWEC20210099) and conducted according to the institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}